News | November 01, 2006

Siemens Forms Full Service Diagnostics Company

Siemens has been given the okay to acquire the diagnostics division of Bayer Healthcare without restrictions. The approval was granted yesterday by the European Commission, following the earlier approval by U.S. antitrust authorities at the beginning of October. For Siemens, this follows the acquisition of the Diagnostic Products Corp. (DPC) at the end of July. Upon completion of the Bayer acquisition, which is expected by early 2007, both companies will be merged and will operate as "Siemens Medical Solutions Diagnostics."
The acquisition of the two companies will make Siemens Medical Solutions number two worldwide in immunodiagnostics. Bayer Diagnostics is also a leader in clinical chemistry with a position in near-patient testing, laboratory automation and hematology (blood cell diagnostics). In addition, the acquisition of Bayer Diagnostics will enable the Siemens Group to get involved in the market for molecular diagnostics based on gene analysis (nucleid acid testing).
"Molecular medicine has huge potential to detect diseases such as cancer at a much earlier stage than what is possible today," said professor Dr. Erich R. Reinhardt, member of the managing board of Siemens AG and president and CEO of Siemens Medical Solutions. "Molecular medicine is already helping physicians choose suitable medications for a particular patient, predict the effects of those medications and personalize patients' treatments. The long-term vision is to identify and treat the molecular causes of diseases long before the patient ever experiences any symptoms, and Siemens is at the forefront of developing these molecular medicine solutions that will transform the future of healthcare."

Related Content

Cambridge University Hospitals NHS Foundation Trust Implements Change Healthcare Enterprise Imaging
News | Enterprise Imaging | April 15, 2019
Change Healthcare successfully implemented its Radiology PACS (picture archiving and communication system), Image...
Visage 7 Enterprise Imaging Platform Highlighted at 2019 SBI/ACR Breast Imaging Symposium
News | Enterprise Imaging | April 05, 2019
Visage Imaging will be exhibiting the latest version of the Visage 7 Enterprise Imaging Platform at the 2019 Society of...
2-D and 3-D digital breast images

Since the widespread adoption of digital imaging and PACS, referring physicians seldom visit radiology reading rooms, substantially reducing a major source of feedback for radiologists. (Shown are 2-D and 3-D digital breast images.) A software module to be described April 5 at the SBI/ACR Breast Imaging Symposium has been providing that feedback for radiologists interpreting breast images at the University of Pittsburgh Medical Center. Image courtesy of Hologic

Feature | Women's Health | March 28, 2019 | By Greg Freiherr
Carestream Health has signed an agreement to sell its healthcare information systems (HCIS) business to Philips Healthcare. Image by geralt on Pixabay

Carestream Health has signed an agreement to sell its healthcare information systems (HCIS) business to Philips Healthcare. This includes its radiology and cardiology PACS and reporting software. Image by geralt on Pixabay 

News | Radiology Business | March 07, 2019
Carestream Health has signed an agr
Dianna Bardo, M.D., is the vice chair of radiology for clinical development at Phoenix Children’s Hospital.

Dianna Bardo, M.D., is the vice chair of radiology for clinical development at Phoenix Children’s Hospital. 

Sponsored Content | Webinar | Enterprise Imaging | March 06, 2019
The webinar "Replacing PACS and the Benefits of Enterprise Partnership in a Pediatric Hospital" will take place at 2
Sponsored Content | Videos | Information Technology | February 28, 2019
Andrew Deutsch, M.D., MBA, chairman and CEO of...